BDBM398134 4-chloro-1-(oxetan-3-yl)-N-(spiro[2.5]octan-5-ylmethyl)-1H-indole-3-carboxamide::US10323000, Compound 68::US10676433, Compound 68
SMILES: Clc1cccc2n(cc(C(=O)NCC3CCCC4(CC4)C3)c12)C1COC1
InChI Key: InChIKey=KVMNMOFFNRRPQH-UHFFFAOYSA-N
Data: 4 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P2X purinoceptor 7 (Homo sapiens (Human)) | BDBM398134 (4-chloro-1-(oxetan-3-yl)-N-(spiro[2.5]octan-5-ylme...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Philipps-University Marburg | Assay Description Agonist-induced pore formation was determined by measuring cellular uptake of YO PRO fluorescence dye in HEK293 transfected with human P2X7 receptor.... | Bioorg Med Chem 16: 8574-86 (2008) BindingDB Entry DOI: 10.7270/Q26M395S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
hIL-1beta (Homo sapiens (Human)) | BDBM398134 (4-chloro-1-(oxetan-3-yl)-N-(spiro[2.5]octan-5-ylme...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a... | US Patent US10676433 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P2X purinoceptor 7 (Homo sapiens (Human)) | BDBM398134 (4-chloro-1-(oxetan-3-yl)-N-(spiro[2.5]octan-5-ylme...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description Agonist-induced pore formation was determined by measuring cellular uptake of YO PRO fluorescence dye in HEK293 transfected with human P2X7 receptor.... | US Patent US10676433 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
hIL-1beta (Homo sapiens (Human)) | BDBM398134 (4-chloro-1-(oxetan-3-yl)-N-(spiro[2.5]octan-5-ylme...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Philipps-University Marburg | Assay Description The activation of P2X7 by ATP leads to a fast transient activation of cells resulting in influx of Ca2+ followed by conversion of pro-IL-1β to a... | Bioorg Med Chem 16: 8574-86 (2008) BindingDB Entry DOI: 10.7270/Q26M395S | |||||||||||
More data for this Ligand-Target Pair |